Stevens Capital Management LP Regeneron Pharmaceuticals, Inc. Transaction History

Stevens Capital Management LP

  • $703 Million
  • Q3 2024

A detailed history of Stevens Capital Management LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Stevens Capital Management LP holds 452 shares of REGN stock, worth $340,369. This represents 0.07% of its overall portfolio holdings.

Number of Shares
452
Holding current value
$340,369
% of portfolio
0.07%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $462,888 - $543,195
452 New
452 $475,000
Q4 2023

Feb 02, 2024
BUY
$775.18 - $881.7 $324,025 - $368,550
418 New
418 $367,000
Q1 2023

May 12, 2023
BUY
$680.49 - $826.97 $156,512 - $190,203
230 Added 29.56%
1,008 $828,000
Q4 2022

Feb 06, 2023
SELL
$705.89 - $766.39 $51,529 - $55,946
-73 Reduced 8.58%
778 $561,000
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $87,243 - $110,096
152 Added 21.75%
851 $586,000
Q2 2022

Aug 11, 2022
BUY
$548.35 - $738.84 $383,296 - $516,449
699 New
699 $413,000
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $2.62 Million - $3.08 Million
-4,407 Closed
0 $0
Q4 2021

Jan 28, 2022
BUY
$543.48 - $670.97 $948,372 - $1.17 Million
1,745 Added 65.55%
4,407 $2.78 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $1.53 Million - $1.81 Million
2,662 New
2,662 $1.61 Million
Q2 2021

Aug 12, 2021
SELL
$472.8 - $558.54 $201,885 - $238,496
-427 Closed
0 $0
Q1 2021

May 11, 2021
BUY
$446.73 - $548.2 $190,753 - $234,081
427 New
427 $202,000
Q4 2020

Feb 08, 2021
SELL
$478.3 - $607.98 $8.66 Million - $11 Million
-18,098 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$544.75 - $658.21 $9.86 Million - $11.9 Million
18,098 New
18,098 $10.1 Million
Q4 2019

Feb 06, 2020
SELL
$274.13 - $376.51 $899,968 - $1.24 Million
-3,283 Closed
0 $0
Q3 2019

Nov 08, 2019
SELL
$273.46 - $318.39 $7.92 Million - $9.22 Million
-28,955 Reduced 89.82%
3,283 $911,000
Q2 2019

Jul 31, 2019
BUY
$299.6 - $414.82 $9.44 Million - $13.1 Million
31,519 Added 4383.73%
32,238 $10.1 Million
Q1 2019

May 03, 2019
BUY
$372.08 - $439.57 $267,525 - $316,050
719 New
719 $295,000
Q1 2018

May 08, 2018
SELL
$315.82 - $393.78 $5.88 Million - $7.33 Million
-18,613 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $6.68 Million - $8.75 Million
18,613
18,613 $7 Million

Others Institutions Holding REGN

# of Institutions
1,532
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Stevens Capital Management LP Portfolio

Follow Stevens Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email